Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:2/20/2009

ale following approval. We have also designed the facility to be used as a contract manufacturing facility during those times (e.g., during certain times in the Phase III study) when we will not be producing Multikine. This lucrative business could quickly become a multi-million dollar revenue generator for CEL-SCI.

  • We presented very promising data on a new rheumatoid arthritis vaccine discovered by CEL-SCI scientists. The data presented was as good as that achieved with Enbrel, a leading treatment for rheumatoid arthritis.

  • We started planning and pricing our global clinical trial designed to lead to marketing approval for Multikine. The recent strength of the dollar will reduce our Phase III study costs by several million dollars.

While we are pleased by these accomplishments, we also recognize that there are major challenges due to the severe financial downturn. This downturn has affected all of us, but we have taken immediate action. We very quickly reduced our expenditures and expanded our discussions with various pharmaceutical companies for a world-wide Multikine partnership. Things are very difficult all around for most companies, but we are seeing new strength in the bigger biotechnology names. This will hopefully trickle down to the smaller ones like us as well. The huge buyouts in the industry, Pfizer buying Wyeth and Roche trying to buy Genentech, will add over $100 billion in liquidity to the industry, and that too should help us down the road.

Let me share with you how we at CEL-SCI are dealing with and planning for recovery from this financial downturn. In our opinion, during such a difficult time as this you cannot rely on one strategy alone. Therefore we are pursuing the following multi-pronged strategy. To
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
2. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
3. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
4. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
5. CEL-SCI Corporation Reports First Quarter Financial Results
6. CEL-SCI Corporation Announces 2007 Financial Results
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014 Research and Markets ... Market in Consumer Healthcare by Application, Sensor Type & ... - 2020" report to their offering. ... been an increasing momentum for consumer healthcare monitoring and ... The consumer healthcare will lessen the healthcare cost of ...
(Date:7/23/2014)... NORTHRIDGE, Calif. , July 23, 2014 ... named the company,s chief customer officer effective immediately. Toll ... overseeing customer sales and marketing, category management, private label ... . In his new global role, Toll will ... and global sales planning. "Toll,s appointment to ...
(Date:7/23/2014)... , July 23, 2014 /PRNewswire-iReach/ -- The Centers ... new five-state Quality Innovation Network-Quality Improvement Organization (QIN-QIO) contract ... Institute (WVMI). Effective August 1, WVMI will ... West Virginia , Pennsylvania , ... and Louisiana.  The Network will engage providers ...
Breaking Medicine Technology:Sensor Market in Consumer Healthcare (Patient Monitoring, Therapeutic, Handheld and Homecare, & Fitness and wellness) - Analysis & Forecast to to 2013 - 2020 2Sensor Market in Consumer Healthcare (Patient Monitoring, Therapeutic, Handheld and Homecare, & Fitness and wellness) - Analysis & Forecast to to 2013 - 2020 3Announcing a New Regional Approach to Medicare Quality Improvement 2
... International, Inc., (OTC Bulletin Board: OXIS ; ... conference call with investors on Tuesday, March 22, 2011 ... During the call Anthony Cataldo, Chief Executive Officer, and ... the Company,s growth strategy, and take questions from call ...
... LA JOLLA, Calif., March 9, 2011 Scientific ... the foundation for the new drug Benlysta® (belimumab), approved today ... the most common type of lupus, is the first in ... attacking its own critical tissues. "I am deeply ...
Cached Medicine Technology:New Lupus Drug Results From Scripps Research Technology 2New Lupus Drug Results From Scripps Research Technology 3New Lupus Drug Results From Scripps Research Technology 4
(Date:7/23/2014)... 23, 2014 (HealthDay News) -- For patients infected with ... may help control both viruses, a small study suggests. ... improve treatment strategies for people with the two diseases. ... antiretroviral medications plays an important role in the management ... study leader Dr. Kenneth Sherman, a professor of medicine ...
(Date:7/23/2014)... the genome resulting from a combination of genetic modifications ... weak predispositions to developing certain kinds of cancer; in ... throughout our lifetime. Although the genetic origins of cancers ... not able to measure the role of non-coding regions ... from the University of Geneva (UNIGE), by studying tissues ...
(Date:7/23/2014)... Ticket Down is a reputable source for ... Stadium . One of the most anticipated matches of ... the Big House in Ann Arbor. Michigan Stadium, the home ... a game between Manchester United from the English Premier League ... held on August 2nd and could be the match that ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 CarePoint Health ... first hospital in New Jersey to receive the da ... robotics platform in the da Vinci series. This 4th ... profound step forward in innovation. The intuitive da Vinci ... a wide spectrum of minimally invasive and complex surgical ...
(Date:7/23/2014)... 23, 2014 This report defines and ... (Asia-Pacific, Europe, the Middle East & Africa, and Americas) ... and geography with analysis and forecasts of the global ... grow from over $10 billion in 2014 to nearly ... 5%. , browse 49 Market Tables and 10 ...
Breaking Medicine News(10 mins):Health News:HIV Meds May Also Help Control Hepatitis C, Study Finds 2Health News:Genetics of cancer: Non-coding DNA can finally be decoded 2Health News:Real Madrid vs. Manchester United Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for ManU vs. Real Madrid Guinness International Champions Cup Tickets 2Health News:Real Madrid vs. Manchester United Tickets Ann Arbor: Ticket Down Slashes Ticket Prices for ManU vs. Real Madrid Guinness International Champions Cup Tickets 3Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 2Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 3Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 4Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 2Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 3Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 4
... ... Bill Schmalfeldt thought his story was worth telling. After being diagnosed with ... Bill wrote a manuscript about the experience. Not only could he not ... it without even reading sample chapters. Believing the story needed to be ...
... ... Introduces Newest, Safest Method of Liposuction , ... NEW YORK, NY (PRWEB) July 1, 2010 -- Dr. Daniel ... approved liposuction procedure, called Nutational Infrasonic Liposuction, more commonly known as Tickle Lipo™. ...
... of medicine,s most successful transplant procedures, doctors continue to ... first time, a team of German and British researchers ... are more likely in patients whose eyes exhibit abnormal ... meta-analysis report appears in July Ophthalmology , the ...
... ... Network of Uganda proudly announces a new fund-raising campaign - ... support of families living with HIV/AIDS and extreme poverty in Uganda. The ... educate their children and provide them with additional nutritional support. The ...
... Reporter , WEDNESDAY, June 30 (HealthDay News) -- Researchers ... areata, a disorder that causes hair to thin and ... other autoimmune diseases, including rheumatoid arthritis and type 1 ... pipeline that could benefit people with hair loss, the ...
... Diane von Furstenberg is ... the 2010 Life Ball on July 17th, 2010 , ... New York, NY (PRWEB) June 30, 2010 -- Diane von Furstenberg is pleased to ... Life Ball on July 17th, 2010., , ,“There is nothing more New York than the Radio ...
Cached Medicine News:Health News:Parkinson's Disease Patient Tells Personal Story to Benefit PD Research; Donates Book Proceeds to PD Charities 2Health News:Parkinson's Disease Patient Tells Personal Story to Benefit PD Research; Donates Book Proceeds to PD Charities 3Health News:Parkinson's Disease Patient Tells Personal Story to Benefit PD Research; Donates Book Proceeds to PD Charities 4Health News:Dr. Daniel Ronel is one of the First in the U.S. to Offer Tickle Lipo™ 2Health News:Dr. Daniel Ronel is one of the First in the U.S. to Offer Tickle Lipo™ 3Health News:Study finds new key to corneal transplant success 2Health News:Mulago Positive Women's Network Announce Their "BONO" Bracelet Fundraiser to Benefit HIV+ Women in Uganda 2Health News:Mulago Positive Women's Network Announce Their "BONO" Bracelet Fundraiser to Benefit HIV+ Women in Uganda 3Health News:Genes Tied to Hair Loss Disorder 2Health News:Genes Tied to Hair Loss Disorder 3Health News:DVF To Bring The Radio City Rockettes To Vienna's Life Ball 2Health News:DVF To Bring The Radio City Rockettes To Vienna's Life Ball 3
Fully lined with cotton material for extra softness against patients skin. The 3 double adjustable soft Velcro® bands provide vertical/downward pressure for adjustable comfort following submuscu...
This compression garment can be used for Breast Augmentation, Augmentation Mammaplasty, Trans Umbilical Breast Augmentation, Transaxillary Submuscular Augmentation....
Sub Pectoral Breast Augmentation Wrap...
Bandeau Bra...
Medicine Products: